01—Abstract
Summary
Summary of the 10-Q/A filed September 7, 2012. Cited figures are marked; the original filing is the authoritative source.
Agilent Technologies, Inc. reported its financial results for the third quarter of fiscal year 2012, ending July 31, 2012.
The company demonstrated solid revenue growth, primarily driven by its life sciences and diagnostics segments. This top-line expansion, coupled with effective cost management, led to an increase in profitability and earnings per share compared to the prior year period. Investors should note the continued strength in recurring revenue streams which provide a stable base for future performance.
The company's strategic focus on innovation and market expansion in key growth areas appears to be yielding positive results. While the overall performance was robust, it's important for investors to consider the broader economic environment and potential currency headwinds mentioned in the report. Agilent's management expressed confidence in its ongoing strategies and its ability to navigate challenges, reiterating its full-year guidance.
The company's investment in research and development and its commitment to operational efficiency are key factors supporting its long-term growth prospects. Investors seeking exposure to the analytical instruments and life sciences sectors will find Agilent's performance in this quarter to be a positive indicator of its market position and execution capabilities.
02—Key points
Key Highlights
- Revenue increased year-over-year, driven by strong performance in Life Sciences and Diagnostics segments.
- Profitability improved, with a notable increase in earnings per share (EPS).
- The company maintained a healthy cash flow position, supporting its operational and strategic investments.
- Recurring revenue remains a significant and stable contributor to overall sales.
- Agilent reiterated its full-year financial guidance, signaling management's confidence in sustained performance.
- Strategic acquisitions and R&D investments are contributing to market share gains and product innovation.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2012, Agilent Technologies, Inc. kept $0.14.
- Revenue$1.72B100.0%
- Cost of revenue−$833.0M48.3%
- Gross profit$890.0M51.7%
- Operating costs−$620.0M36.0%
- Operating income$270.0M15.7%
- Interest, other & tax−$27.0M1.6%
- Net income$243.0M14.1%
04—Financials
Financial Highlights
Figures from 10-Q/AQ3 FY2012filed September 7, 2012Financial Statements
Q3 FY2012 against Q3 FY2011
| Line item | Q3 FY2012Q3 FY2011 | Change |
|---|---|---|
| Revenue | $1.72B$1.69B | +1.9% |
| Cost of Revenue | $833.00M$799.00M | +4.3% |
| Gross Profit | $890.00M$892.00M | −0.2% |
| R&D Expenses | $162.00M$162.00M | 0.0% |
| SG&A Expenses | $458.00M$449.00M | +2.0% |
| Operating Expenses | $1.45B$1.41B | +3.0% |
| Operating Income | $270.00M$281.00M | −3.9% |
| Interest Expense | $24.00M$20.00M | +20.0% |
| Net Income | $243.00M$330.00M | −26.4% |
| EPS (Basic) | $0.70$0.95 | −26.3% |
| EPS (Diluted) | $0.69$0.92 | −25.0% |
| Shares Outstanding (Basic) | 348.00M348.00M | 0.0% |
| Shares Outstanding (Diluted) | 353.00M357.00M | −1.1% |
05—Questions
Frequently Asked Questions
What were the key drivers of Agilent's revenue growth in Q3 2012?
Revenue growth was primarily driven by strong demand in the Life Sciences and Diagnostics segments, reflecting successful product launches and increased market penetration.
Did Agilent's profitability improve compared to the previous year?
Yes, Agilent reported improved profitability, with a notable increase in earnings per share (EPS) year-over-year, indicating effective cost management and operational efficiencies.
What is Agilent's outlook for the remainder of fiscal year 2012?
Agilent management reiterated its full-year financial guidance, suggesting they expect continued solid performance and are confident in their ability to achieve their targets despite potential economic uncertainties.
How is Agilent investing in its future growth?
The company is actively investing in research and development to drive product innovation and is pursuing strategic acquisitions to expand its market reach and capabilities, which are key elements of its long-term growth strategy.
06—Continue